Literature DB >> 22965150

Screening: Cervical cancer--should we abandon cytology for screening?

Chris J L M Meijer, Johannes Berkhof.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22965150     DOI： 10.1038/nrclinonc.2012.161

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

Review 2.  Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Kimberly K Vesco; Michelle Eder; Jennifer S Lin; Caitlyn A Senger; Brittany U Burda
Journal:  Ann Intern Med       Date:  2011-10-17       Impact factor: 25.391

3.  Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.

Authors:  Dorien C Rijkaart; Johannes Berkhof; Folkert J van Kemenade; Veerle M H Coupe; Albertus T Hesselink; Lawrence Rozendaal; Danielle A M Heideman; Ren H Verheijen; Saskia Bulk; Wim M Verweij; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

4.  Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.

Authors:  Albertus T Hesselink; Daniëlle A M Heideman; Renske D M Steenbergen; Veerle M H Coupé; Renee M Overmeer; Dorien Rijkaart; Johannes Berkhof; Chris J L M Meijer; Peter J F Snijders
Journal:  Clin Cancer Res       Date:  2011-03-09       Impact factor: 12.531

5.  Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Authors:  Philip E Castle; Mark H Stoler; Thomas C Wright; Abha Sharma; Teresa L Wright; Catherine M Behrens
Journal:  Lancet Oncol       Date:  2011-08-22       Impact factor: 41.316

6.  A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.

Authors:  Mark Schiffman; Andrew G Glass; Nicolas Wentzensen; Brenda B Rush; Philip E Castle; David R Scott; Julie Buckland; Mark E Sherman; Greg Rydzak; Peter Kirk; Attila T Lorincz; Sholom Wacholder; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

7.  Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

Authors:  K Ulrich Petry; Dietmar Schmidt; Sarah Scherbring; Alexander Luyten; Axel Reinecke-Lüthge; Christine Bergeron; Friedrich Kommoss; Thomas Löning; Jaume Ordi; Sigrid Regauer; Ruediger Ridder
Journal:  Gynecol Oncol       Date:  2011-03-21       Impact factor: 5.482

8.  Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Authors:  Pontus Naucler; Walter Ryd; Sven Törnberg; Anders Strand; Göran Wadell; Kristina Elfgren; Thomas Rådberg; Björn Strander; Ola Forslund; Bengt-Göran Hansson; Björn Hagmar; Bo Johansson; Eva Rylander; Joakim Dillner
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

9.  Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

Authors:  Philip E Castle; Andrew G Glass; Brenda B Rush; David R Scott; Nicolas Wentzensen; Julia C Gage; Julie Buckland; Greg Rydzak; Attila T Lorincz; Sholom Wacholder
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

Review 10.  Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Authors:  Marc Arbyn; Guglielmo Ronco; Ahti Anttila; Chris J L M Meijer; Mario Poljak; Gina Ogilvie; George Koliopoulos; Pontus Naucler; Rengaswamy Sankaranarayanan; Julian Peto
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641
  10 in total
  1 in total

1.  The use of molecular markers for cervical screening of women living with HIV in South Africa.

Authors:  Wieke W Kremer; Marjolein van Zummeren; Erika Breytenbach; Karin L Richter; Renske D M Steenbergen; Chris J L M Meijer; Greta Dreyer
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.